London-based investment firm AKO Capital significantly decreased its position in medical technology company Stryker Corporation (SYK) during the second quarter of 2026. According to a recent SEC filing, which reflects holdings as of June 30, 2026, AKO Capital sold over 229,000 shares, reducing its stake by nearly 92%. This transaction lowered the reported value of their holding to just over $6,000.
Investors are reminded that 13F filings are disclosed with a delay, so this report reflects a portfolio change that occurred between March 31 and June 30, 2026. The filing does not disclose the specific reasons for the trade. Recently, Stryker announced a significant contract modification with the U.S. Defense Logistics Agency. AKO Capital is known for its long-term investment philosophy, focusing on high-quality companies.